Pressmeddelanden, rapporter och bolagsmeddelande för Cessatech
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech reports first patient dosed in pivotal trial of lead product candidate
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Second quarter report Q2-2022 – green light for the pivotal trial 0205
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Good things are worth waiting for - welcome to the second half of 2022!
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech reports Regulatory Green Light for trial 0205, the pivotal trial for CT001 - first patient expected shortly
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech reports last patient dosed in pharmacokinetic trial in children of lead candidate
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: First quarter report Q1-2022 - preparing for the pivotal trial
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Newsletter #6 - Mar 2022
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Minutes from the Annual General Meeting in Cessatech A/S
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech reports successful outcome of bioavailability trial 0204 with CT001
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech A/S publishes annual report for the fiscal year 2021